MDT vs SYK
Medtronic and Stryker Corporation, both Healthcare
Stryker Corporation is the larger company at $120B against $102B. On trailing earnings MDT is the cheaper of the two at a P/E of 21.7 against 28.7, a gap that is only a bargain if the two are growing at similar rates. Over the past year MDT returned -5.3% against -26% for SYK. The RyuScore puts SYK ahead, 66 against 62 out of 100.
| Figure | MDT | SYK |
|---|---|---|
| Last close | $88.48 | $277 |
| Market cap | $102B | $120B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 21.7 | 28.7 |
| Dividend yield | 3.2% | n/a |
| 1-year return | -5.3% | -26% |
| 5-year return | -21% | +7.6% |
| RyuScoresector-relative, 1–10 | 62/100 | 66/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Medtronic
Revenue of $9.8B in Q1 2027, net income $1.5B. Its largest reported line is Total Other Countries Excluding Ireland, 100% of the disclosed total.
Stryker Corporation
Revenue of $6.6B in Q2 2026, net income $1.3B. Its largest reported line is Traumaand Extremities, 16% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.